Brief: Neuroscientific Biopharmaceuticals To Acquire Stemsmart Patented Stem Cell Technology
16/04/2025 02:29
April 16 (Reuters) - NeuroScientific Biopharmaceuticals Ltd NSB.AX: TO ACQUIRE STEMSMART PATENTED STEM CELL TECHNOLOGY RECEIVES FIRM COMMITMENTS TO RAISE A$3.5 MILLION PLACEMENT AT A$0.035 PER SHARE Further company coverage: NSB.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO